| 1. GENERAL INFORMATION |
| |
1.1 |
|
What is IMPACT? |
| |
1.2 |
|
What are the advantages of the IMPACT System? |
| |
1.3 |
|
What is protein splicing? |
| |
1.3.5 |
|
Table of IMPACT Vectors and Applications |
| |
1.4 |
|
What vectors are included in the IMPACT Kit? |
| |
1.5 |
|
What are the features of other E. coli IMPACT vectors? |
| |
1.5.5 |
|
What are the components of the IMPACT Kit? |
| |
1.6 |
|
Which inteins are used in the IMPACT vectors? |
| |
1.7 |
|
What causes the cleavage? |
| |
1.7.5 |
|
If my target protein is sensitive to DTT , which vector(s) should I use? |
| |
1.8 |
|
What is the success rate of procaryotic protein purification? |
| |
1.9 |
|
What size range of proteins have been purified? |
| |
1.10 |
|
IMPACT References |
| |
1.11 |
|
References From IMPACT Users |
| |
1.12 |
|
InBase, the Intein Database |
| 2. VECTORS |
| |
2.1 |
|
The IMPACT Kit vectors |
| |
2.1.5 |
|
What are the polylinkers of the IMPACT vectors? |
| |
2.2 |
|
Description of the pTYB expression vectors |
| |
2.2.1 |
|
Comparison between the C-terminal fusion vectors (pTYB1) and N-terminal fusion vectors ( pTYB11) . |
| |
2.2.2 |
|
Description of the pTWIN expression vectors |
| |
2.2.3 |
|
Comparison between the C-terminal vectors |
| |
2.3 |
|
Description of the pTXB expression vectors |
| |
2.4 |
|
Description of the pKYB1 expression vector |
| |
2.5 |
|
Description of the pCYB expression vectors |
| |
2.6 |
|
Do the pTYB, pTXB, pTWIN or pCYB vectors carry any marker for the selection of the recombinant plasmids? |
| |
2.7 |
|
Which E.coli host strains can be used with the IMPACT vectors? |
| |
2.8 |
|
How can the target gene be transferred from the pCYB vectors into the pTYB vectors? |
| |
2.9 |
|
Can single-stranded DNA be prepared from the pTYB, pTXB, pTWIN and pCYB vectors? |
| |
2.10 |
|
In the case of the C-terminal fusion vectors, pTYB1,2,3 and 4, which residues at the C-terminal of the target protein
may inhibit cleavage or cause in vivo cleavage? (For pTXB1,3 see 2.12) |
| |
2.11 |
|
In the case of the N-terminal fusion vectors, pTYB11 and 12, which residues at the N-terminal of the target protein may
inhibit cleavage or cause in vivo cleavage? |
| |
2.12 |
|
In the case of the C-terminal fusion vectors pTXB1 and 3, which residues at the C-terminal of the target protein may inhibit
cleavage or cause in vivo cleavage? |
| 3. CLONING |
| |
3.1 |
|
Should I clone my target gene into the C-terminal fusion vectors or N-terminal fusion vectors? |
| |
3.1.5 |
|
What can I do if my gene of interest has a SapI and I want to make an exact fusion in pTXB1 or pTYB1? |
| |
3.2 |
|
What are the features of other E. coli IMPACT vectors? |
| |
3.3 |
|
How to design PCR Primers for cloning into C-terminal fusion vectors pTXB, pTYB (pTYB1,2,3 and 4) or pCYB vectors? |
| |
3.3.3 |
|
Cloning into pTWIN Vectors |
| |
3.3.5 |
|
Primer design for pTWIN vectors |
| |
3.4 |
|
Which residues or sequence should be inserted at the cleavage site to improve controllable cleavage in C-terminal pTYB
vectors (pTYB1,2,3 and 4)? |
| |
3.5 |
|
How should primers with a SapI site be designed for cloning the gene of interest into pTYB1/pTXB1 or pTYB3/pTXB3
vectors? |
| |
3.6 |
|
How should a cloning strategy for C-terminal fusions (pTYB1,2,3,4) be designed if the gene of interest contains both NdeI
and NcoI sites? |
| |
3.7 |
|
Can XmaI be used for cloning the gene of interest into pTYB2 or pTYB4 vector? |
| |
3.8 |
|
How can the recombinant plasmid (pTYB, pTXB or pCYB vector with an insert) be analyzed by restriction digestion when the
SapI or SmaI site is used for cloning? |
| |
3.9 |
|
In the case of C-terminal fusion vectors, if the EcoRI site is used as the 3´ cloning site, which vector should
be chosen? |
| |
3.9.5 |
|
What primers are available to sequence the insert? |
| 4. EXPRESSION |
| |
4.1 |
|
Recommended strains for the IMPACT system |
| |
4.2 |
|
Which E. coli host strains can be used with the pCYB vectors? |
| |
4.3 |
|
Should DTT be added to the SDS Sample Buffer for SDS PAGE analysis? |
| |
4.4 |
|
How many positive clones should be checked for expression and purification? |
| |
4.5 |
|
What factors contribute to the low expression of some proteins? |
| |
4.5.5 |
|
How can I optimize expression? |
| |
4.6 |
|
What causes lower yields for eucaryotic proteins using the IMPACT system in E.coli ? |
| |
4.7 |
|
What are some suggestions for expressing a toxic gene? |
| |
4.8 |
|
Should a pTXB or pTYB vector be used as a control for expression? |
| |
4.9 |
|
Can the intein-CBD enhance solubility? |
| |
4.9.5 |
|
What if my fusion protein is insoluble? |
| |
4.10 |
|
Is there an alternative way to break cells other than sonication? |
| |
4.11 |
|
Are there antibodies available for western blot detection? |
| |
4.12 |
|
What are the common problems associated with western blot analysis? |
| |
4.13 |
|
What does this mean if Western blot analysis with anti-CBD serum detects a 28 kDa product (when pTXB1,3 are used) or
a 55 kDa product (when the C-terminal fusion vectors are used) and not the fusion precursor? |
| |
4.14 |
|
Is in vivo cleavage an all or nothing phenomenon? |
| |
4.15 |
|
General Troubleshooting |
| 5. PURIFICATION AND ON-COLUMN CLEAVAGE |
| |
5.1 |
|
What is the binding capacity of the resin? |
| |
5.2 |
|
How can the binding efficiency be improved? |
| |
5.3 |
|
The protein to be purified requires DTT or 2-mercaptoethanol in the Column Buffer. What effect will this have on cleavage? |
| |
5.4 |
|
Which reducing reagents can be used to stabilize a thiol-dependent enzyme? |
| |
5.5 |
|
Will protease inhibitors interfere with the intein-mediated cleavage reaction? |
| |
5.6 |
|
Is the 0.1% Triton X-100 in the Column Buffer necessary or could it be replaced by a comparable concentration of other
detergent? |
| |
5.7 |
|
If the fusion protein forms inclusion bodies, can I try to purify protein under denaturing conditions? |
| |
5.8 |
|
If the target protein is sensitive to DTT, are there alternative means to induce on-column cleavage? |
| |
5.9 |
|
How can an on-column cleavage reaction be carried out if the target protein has optimal activity at low salt? |
| |
5.10 |
|
How can E.coli GroEL be eliminated from the elution sample? |
| |
5.11 |
|
The target protein is not eluted after DTT treatment, but is present on the chtin column |
| |
5.12 |
|
What are the solutions to reduce co-purification of CBD fusion proteins? |
| |
5.13 |
|
If the on-column cleavage is inefficient and the fusion protein is the major product on the chitin column, what should
I do? |
| |
5.14 |
|
How can cleavage of the fusion protein be slowed down during the purification process? |
| |
5.15 |
|
How do I remove DTT after cleavage? |
| |
5.16 |
|
When I use the N-terminal fusion vectors (pTYB11 and pTYB12), how do I remove the small peptide co-eluted with the target
protein? |
| |
5.17 |
|
Are there known ways to accelerate the hydrolysis of DTT from the C-terminal of the target protein in a controlled manner? |
| |
5.17.5 |
|
When using the N- and C-terminal fusion construct (pTWIN system) to generate cyclic proteins both the linear and circular
forms are purified from the chitin resin. Is there a way to get only the circular species? |
| |
5.18 |
|
Can the chitin beads be regenerated? |
| 6. APPLICATIONS: PROTEIN LIGATION AND LABELING |
| |
6.1 |
|
What is Intein-mediated Protein Ligation (IPL)? |
| |
6.2 |
|
What has IPL been used for? |
| |
6.2.5 |
|
Can IPL be used to generate substrates for enzyme analysis? |
| |
6.3 |
|
What vectors are suitable for IPL and cyclization? |
| |
6.4 |
|
What cleavage reagent should be used for IPL? |
| |
6.5 |
|
Which products should be ordered for IPL? |
| |
6.6 |
|
What are the column buffers recommended for chitin chromatography and on-column cleavage? |
| |
6.7 |
|
What is the protocol for ligation? |
| |
6.8 |
|
Which residues at the C-terminus of the target protein may inhibit cleavage or cause in vivo cleavage when the pTXB vectors
are used? |
| |
6.9 |
|
What are the sequencing primers for the pTXB vectors? |
| |
6.10 |
|
References for Intein-mediated Protein Ligation(IPL) |
| |
6.11 |
|
Can the IMPACT System be used in other expression systems? |
| |
6.12 |
|
How can the C-terminal fusion vectors be used to label the C-terminus of the target protein? |
| |
6.13 |
|
Can the IMPACT System be used to pull out proteins from E. coli or mammalian cell extracts which react with the
target protein? |
| |
6.14 |
|
Can the IMPACT System be used to purify peptides? |
| |
6.15 |
|
What is your recommended protocol for scaling-up the chitin column? |
| 7. CHITIN-BINDING DOMAIN (CBD) |
| |
7.1 |
|
What is chitin? |
| |
7.2 |
|
Where does the chitin binding domain (CBD) in the IMPACT system originate from? |
| |
7.3 |
|
Does the Bacillus circulans CBD have an affinity for low molecular weight chitin (2 to 6 GlcNAc residues)? |
| |
7.4 |
|
Is there any method to elute the complete fusion Protein from the chitin column? For instance, by eluting with high concentrations
of GlcNAc or low pH? |
| |
7.4.5 |
|
Can the chitin beads be regenerated? |
| |
7.5 |
|
Can you provide additional information about the chitin beads? |
| |
7.6 |
|
What is the Km of the chitin binding domain? |
| |
7.7 |
|
What is the specificity of the CBD to chitin, cellulose, and polyglucans? |
1. General Information
| 1.1 What is IMPACT? |
| |
IMPACT, Intein-Mediated Purification with an Affinity Chitin-binding Tag, is a novel protein purification system that
allows recombinant proteins to be purified without affinity tag in a single chromatographic step. This method was developed at New
England Biolabs (NEB) from studies of the mechanism of protein splicing (see references in 1.10 and 1.11).
It distinguishes itself from all other purification systems by its ability to purify a recombinant protein with its native sequence
by a single affinity column, without the use of a protease. The IMPACT system utilizes the inducible self-cleavage activity of an engineered
protein splicing element (intein) to separate the target protein from the affinity tag. The target protein is fused to a tag consisting
of the intein and the chitin binding domain (CBD) which allows affinity purification of the fusion precursor on the chitin column.
The intein undergoes specific cleavage by a thiol reagent or pH and temperature shift which releases the target protein from the chitin-bound
tag resulting in a single column purification of the target protein.
The IMPACT system includes a series of E.coli expression vectors, which utilize engineered
inteins of 134-454 amino acid residues. These vectors are designed for protein expression and purification in E.coli as well as protein
manipulations such as protein labeling, ligation and cyclization.
The IMPACT Kit, as well as vectors sold separately, is available to meet your research goal. The compatibility of the multiple cloning
sites of the vectors allows insertion of the same target gene fragment into different vectors for optimal expression and purification.
The gene encoding the target protein is inserted into the multiple cloning site of the IMPACT expression vector, to create an in-frame
fusion between the target gene and the affinity tag consisting of the intein and chitin binding domain (CBD, 52 amino acid residues)
When crude extracts of induced E.coli cells are passed over a chitin column, the fusion protein
of the target protein intein-CBD binds to the chitin beads while all other contaminants are washed off the column. On-column cleavage
is induced at 4°C by addition of a reducing agent (such as DTT) or temperature and pH shift (pTWIN vectors). The target protein
is released while the intein-CBD tag remains bound to the column, resulting in a single-column purification of the target protein.
The IMPACT Kit (#E6901) contains expression vectors, which allow the fusion of the cleavable
intein tag to either the C-terminus (pTXB1) or N-terminus (pTYB11) of the target protein. This flexibility in fusion protein construction
maximizes the probability of successful expression and purification of a target protein.
The pTWIN vectors (#N6951S and #N6952S)
offer many advantages: (1) the facile isolation of native proteins without the use of a thiol reagent - using pH and temperature shift
(Intein 1) (2) the isolation of proteins with an N-terminal cysteine [for intein mediated ligation (IPL)] or residue other than methionine
without the use of exogenous proteases which can be costly and non-specific (3) the purification of proteins with a C-terminal thioester
for use in IPL reactions which can insert non-coded amino acids into a protein or label a bacterially expressed protein (4) the generation
of circular protein species.
All vectors use a T7 promoter and the lacI gene to provide stringent control of the fusion gene expression. Binding of the lac repressor
to the lac operator sequence immediately downstream of the T7 promoter suppresses basal expression of the fusion gene in the absence
of IPTG induction. All vectors carry the Ampr gene marker (the bla gene), which conveys ampicillin resistance to the host strain,
except for pKYB1 (#N6706S) , which carries the kanamycin resistance gene.
top |
| |
| 1.2 What are the advantages of the IMPACT System? |
| |
- Single column purification - no additional steps to remove the affinity tag
- Yields native amino acid sequence
- Fusion of a target protein to either the C-terminus or N-terminus of the intein tag
- Proteases are NOT required to remove the affinity tag from the target protein
- Use of either thiol reagent or pH and temperature shift to induce on-column cleavage
- Isolation of proteins with or without an N-terminal methionine residue
- Production of proteins possessing an N-terminal cysteine and/or C-terminal thioester for use in protein labeling, ligation and
cyclization [See Part 6: Applications: Protein ligation and labeling]
- T7 Promoter for high-level expression and tight regulation of transcription
- Protein semisynthesis - The ability to create a thioester at the C-terminus for ligation with a N-terminal containing cysteine
peptide or tag [See Part 6: Applications: Protein ligation and labeling]
- The ability to label the C-terminus of the target protein [See Part 6: Applications: Protein ligation and labeling]
top
|
| |
| 1.3 What is protein splicing? |
| |
Protein splicing is defined as a post-translational processing event in which an internal protein segment, the intein,
is excised from a protein precursor and the two external polypeptide sequences, the exteins, are then ligated together, resulting in
the production of two distinct proteins. Many inteins, have been shown to mediate splicing without other protein cofactors. These self-splicing
inteins have been engineered to undergo peptide bond cleavage at their N- and/or C- terminal junction. For more information on inteins
please go to Inbase, the Intein Database and Registry: http://www.neb.com/neb/inteins.html
top |
1.3.5 Which kit should I use? / Table: IMPACT Vectors and Applications |
| |
The following table describes some important considerations when choosing a vector: for protein purification:
a) Site of target protein fusion -
- May determine if target protein is active as a fusion
- May increase or decrease level of expression
- May affect cleavage reactions
b) Cleavage site residue preference: actual cleavage efficiency is dependent on the adjacent residues as well as the folding of the fusion
protein.
c) Thiol requirement - If your target proptein is sensitive to thiol reagents, use of the TWIN vectors is warranted.
Summary of IMPACT vectors
| Vectors |
Site of target protein fusion |
Intein Tag (kDa) |
Recommeded cloning sites |
Preferred residues at cleavage sitea |
Method of cleavageb,c |
Applications |
pTXB1
pTXB3 |
C-terminus |
Mxe GyrA intein (28) |
NdeI-SapI
(or SpeI) |
M, Y, F, LEM
(Unfavorable residues-
S, P, E, D) |
DTT (or MESNA)
pH 8.0-8.5, 4°C |
Purification; C-terminal thioester for ligation and modification |
pTYB11
pTYB12 |
N-terminus |
Sce VMA1 intein
(56) |
SapI-PstI
BsmI (or NdeI)-NotI |
A, Q, M, G, L, N, W, F, Y
(Unfavorable residues-
P, S, C, T, R) |
DTT c
pH 8-8.5, 25° C |
Purification |
pTYB1
pTYB2
pTYB3
pTYB4 |
C-terminus |
Sce VMA1 intein (56) |
NdeI- SapI
NdeI-SmaI (or XhoI)
NcoI-SapI
NcoI-SmaI (or XhoI) |
G, LEG
(Unfavorable residues-
P, C, N, D, R) |
DTT
(or MESNA)
pH 8-8.5
4°C |
Purification and ligation |
| pTWIN1 |
C-terminus
(Intein 2)
|
Mth RIR1 intein
(28) |
NdeI-SapI (or SpeI) |
M, Y, F, LEM
(Unfavorable residues-
S, P, E, D) |
Purification; C-terminal thioester for ligation and modification |
| pTWIN2 |
C-terminus
(Intein 2) |
Mth RIR1 intein
(22) |
NdeI-SapI (or SpeI) |
G, A, LEG
(Unfavorable
residues- P, E, D) |
| pTWIN1d |
N-terminus
(Intein 1)
|
Ssp DnaB
mini-intein
(27)
|
SapI-SapI
SapI-PstI (or BamHI)
BsrGI-PstI (or BamHI) |
C, S, A, G, M,
T, CRAM (Unfavorable
residues- P) |
pH 6-7
25° C |
Purification; Defined N-terminus (e.g. Cys); Ligation |
| pTWIN1d |
N-terminus
(Intein 1)
&
C-terminus
(Intein 2) |
Ssp DnaB
mini-intein
(27)
Mxe GyrA intein
(28) |
SapI-SapI |
C, S, A, G, M,
T, CRAM (Unfavorable
residues- P)
M, Y, F, LEM
(Unfavorable residues- S, P, E, D) |
Step 1:
pH 6-7
25° C
Step 2:
DTT (or MESNA)
pH 8-8.5
4° C |
Purification; Defined N-terminus (e.g. Cys); Ligation and cyclizatione |
| pTWIN2d |
N-terminus
(Intein 1)
&
C-terminus
(Intein 2) |
Ssp DnaB
mini- intein
(27)
Mth RIR1 intein
(22) |
SapI-SapI |
C, S, A, G, M,
T, CRAM (Unfavorable
residues- P)
G, A, LEG (Unfavorable
residues- P, E D) |
a. Actual cleavage efficiency is dependent on the adjacent residues as well as the folding of the fusion
protein.
b. Dithiothreitol (DTT) is used only for protein purification. 2-mercaptoethanesulfonic acid (MESNA) is
used for isolation of proteins possessing a C-terminal thioester for ligation, labeling and cyclization.
c. Cysteine can be used in the place of DTT.
d. pTWIN vectors allow for induction of Ssp DnaB (intein 1) intein cleavage by a pH/temperature shift.
e. When creating circular proteins it is typical that the linear form will co-purified, requiring a further
step to separate the two protein species.
top |
| |
| 1.4 What vectors are included in the IMPACT kit? |
| |
The IMPACT kit includes three E. coli expression vectors, which allows for
the fusion of the cleavable intein tag to either the C-terminus (pTXB1) or N-terminus (pTYB11) of the target protein.
The pMXB10 vector serves as a positive control for expression and purification and can also be used as a cloning vector.
pTXB1 (#N6707S) contains a mini-intein from the Mycobacterium xenopi gyrA gene (Mxe
GyrA intein; 198 amino acid residues) that has been modified to undergo thiol-induced cleavage at its N-terminus (Evans, T.C., et al.
(1998) Semisynthesis of cytotoxic proteins using a modified protein splicing element. Protein Sci. 7, 2256–2264; Southworth,
M. W., et al.(1999) BioTechniques 27, 110–120). The vector allows for the purification of a target protein without any extra
amino acids by cloning into the NdeI and SapI sites. The target protein is fused at its C-terminus to a self-cleavable intein tag (~28
kD) that contains the chitin binding domain (CBD, 6 kDa) allowing for affinity purification of the fusion precursor on a chitin column.
The pTYB11 (#N6701S) vector utilizes an intein from the Saccharomyces cerevisiae VMA1
gene (Sce VMA1 intein; 454 amino acids)(Chong, S. et al. (1998) Utilizing the C-terminal cleavage activity of a protein splicing element
to purify recombinant proteins in a single chromatographic step. Nucl. Acids Res. 26, 5109–5115; Chong, S., et al. (1998) Modulation
of protein splicing of the Saccharomyces cerevisiae vacuolar membrane ATPase intein. J. Biol. Chem. 273, 10567–77). The target
protein is fused at its N-terminus to a self-cleavable VMA1 intein-CBD tag (56 kD); the tag allows for the affinity purification of
the fusion precursor on a chitin column. The vector is designed to allow for purification of a target protein without any extra amino
acids, or without an N-terminal methionine residue, by cloning its 5’ end into the SapI site.
The control vector, pMXB10 (#N6903S), derived from pTXB1 carries the control target
protein, maltose-binding protein (MBP), already inserted upstream of the Mxe GyrA intein-CBD. Induction yields the MBP-GyrA intein-CBD
fusion which, when cleaved, results in the elution of MBP. The polylinker regions flanking the coding region for MBP can conveniently
be used to clone a gene of interest. However, after intein cleavage the target protein will contain additional amino acids at its C-terminus,
including (LEY), which has had a high rate of successful cleavage.
The IMPACT vectors utilize a T7 promoter to provide stringent control of expression of the fusion gene in E.
coli (Dubendorff, J. W. and Studier, F. W. (1991) Controlling basal expression in an inducible T7 expression system by blocking
the target T7 promoter with lac repressor. J. Mol. Biol. 219, 45–59.). The IMPACT vectors carry the Ampr gene marker (the bla
gene), which conveys ampicillin resistance to the host strain; one vector, pKYB1 (#N6706S),
is kanamycin resistant (available separately).
top |
| |
| 1.5 What are the features of other E. coli IMPACT vectors? |
| |
The C-terminal fusion vectors, pTYB1(#N6701) and pTYB2 (#N6702),
utilize an intein from the Saccharomyces cerevisiae VMA1 gene [Sce VMA intein; Kane, et al., (1990) Science,250, 651-657]. The intein
has been modified to undergo a self-cleavage reaction at its N-terminal junction at 4°C when induced by thiol reagents such as
DTT. pTYB1 and pTYB2 use ATG of the NdeI site in the multiple cloning region for translation initiation. The gene encoding the target
protein is inserted into the NdeI/SapI site for pTYB1 and the NdeI/SmaI site for pTYB2 to create a fusion between the C-terminus of
the target gene and the N-terminus of the gene encoding the intein. DNA encoding a chitin binding domain (CBD) from Bacillus circulans
[Watanabe, T., et al. (1994) The role of the C-terminal domain and type III domains of chitinase A1 from Bacillus circulans WL-12 in
chitin degradation J. Bacteriol. 176, 4465–4472] has been added to the C-terminus of the intein to allow affinity purification
of the 3-part fusion.
pTYB12 (#N6902S) is a N-terminal fusion vector similar to pTYB11 in which the N-terminus
of the target protein is fused to the C-terminus of the intein tag consisting of the intein and CBD. This vector allows the use of
BsmI or NdeI for cloning the 5’ end
of the target gene (instead of the SapI site in pTYB11). The CBD is inserted in a loop region of the engineered Sce VMA intein such
that the cleavage activity of the intein is not affected. The engineered intein can undergo cleavage at its C-terminus triggered by
thiol-induced cleavage at its N-terminal junction.
pTXB1, pTYB1 and pTYB11 contain a SapI cloning site, which allows the target gene to be cloned adjacent to the cleavage site of the
intein tag; this results in the purification of a target protein without any vector-derived, non-native residues attached to its terminus.
For pTXB1 and pTYB1 only the SapI site should be used to clone the 3´ end of the target gene and for pTYB11 only the SapI site
should be used to clone the 5´ end of the target gene . This strategy will result in the fusion of the target gene adjacent to
the intein tag (and the cleavage site). The target protein can be purified without any extra non-native residues. The use of SapI site
also allows for the addition of amino acid residues favorable for cleavage (by engineering them into the coding region of the primers).
Furthermore, pTYB1 and pTXB1 contain the same or compatible restriction sites in the multiple cloning region. This flexibility in
fusion protein construction maximizes the probability of successful expression and purification of a target protein.
Use of pTYB2 or pTYB12 yields a target protein with extra residue(s) added to its C-terminus or N-terminus, respectively, after the
cleavage of the intein tag. For instance, cloning the 3´ end of a target gene using the SmaI site in pTYB2 adds an extra glycine
residue to the C-terminus of the target protein. Likewise, cloning the 5´ end of a target gene using the NdeI site in pTYB12
adds four extra residues (Ala-Gly-His-Met) to the N-terminus of the target protein. These extra residues have been shown to sucessfully
cleave.
The IMPACT vectors use a T7/lac promoter and the lacI gene to provide stringent control of the fusion gene expression. Binding of
the lac repressor to the lac operator sequence immediately downstream of the T7 promoter suppresses basal expression of the fusion
gene in the absence of IPTG induction. The vectors also contain the origin of DNA replication from bacteriophage M13, which allows
for the production of single-stranded DNA by helper phage (M13KO7 helper phage, #N0315)
superinfection of cells bearing the plasmid. Except in the cases of pTYB11 and pTYB12, the background transcription is further reduced
by the placement of five tandem transcription terminators (rrnB T1) upstream of the T7 promoter sequence. All IMPACT vectors carry
the Ampr gene marker (the bla gene), which conveys ampicillin resistance to the host strain except for pKYB1 (#N6706S),
which carries the kanamycin resistance gene.
There are three TWIN E. coli expression vectors - pTWIN1(#N6951),
pTWIN2 (#N6952) and pTWIN-MBP1(#N6953).
The pTWIN vectors allow for the fusion of a mini-intein tag to the C-terminus, N-terminus, or both the C- and N-termini of a target
protein, depending on the cloning sites chosen. Fusion of the intein tag to the C-terminus of the target protein allows thiol-dependent
purification of the target protein from the chitin resin. This thiol-dependent cleavage permits the purification of proteins with a
C-terminal thioester for use in intein-mediated protein ligation (IPL) reactions. IPL reactions can be used to incorporate fluorescent
or biotinylated tags and/or non-coded amino acids into the C-terminus of a bacterially-expressed protein (see Part 6).
Alternatively, fusion of the intein tag (Intein1 or Ssp DnaB intein) to the N-terminus of the target protein permits the release of
the target protein from the chitin resin by a pH (from 8.5 to 6) and temperature (from 4 °C to 20 - 25 °C) shift. This is advantageous
for the purification of proteins that are sensitive to reducing agents such as DTT or 2-mercaptoethanol. Also, the C-terminal fusions
can be used to purify proteins with an N-terminal amino acid other than Met. Finally, insertion of the target gene between two self-cleaving
intein tags allows the generation of cyclic protein species which posses a peptide bond at the site of ligation.[See Part
6: Applications: Protein ligation and labeling]
Both pTWIN1 and pTWIN2 contain SapI sites which allow the gene of interest to be cloned between the intein tags without the addition
of any vector derived residues at either termini of the target gene. The pTWIN1 and pTWIN2 vectors both use a modified Ssp DnaB intein
(154 amino acid residues) as intein1 and differ only in the identity of intein 2. pTWIN1 uses a modified Mxe GyrA intein (198 amino
acid residues, same as in pTXB1) while pTWIN2 uses a modified Mth RIR1 intein (134 amino acid residues). However, both pTWIN1 and pTWIN
2 contain the same multiple cloning sites, which simplifies the insertion of a target gene into both vectors to determine the optimal
expression plasmid.
pTWIN-MBP1 can be used both as a control vector and a cloning vector. Cloning of a target gene into the NcoI to SacI sites in pTWIN-MBP1
adds 3 amino acids to the protein's N-terminus and 23 amino acids to its C-terminus. When additional amino acids will not alter the
behavior of the target protein this linker may increase the yields of circular species. In the case of the 42 kDa E. coli maltose binding
protein (MBP) these extra amino acids were found to permit cyclization whereas without these linker sequences no circular MBP was detected
[Evans, T.C. Jr., Benner, J., and Xu, M.-Q. (1999) The cyclization and polymerization of bacterially-expressed proteins using modified
self-splicing inteins. J. Biol. Chem.274, 18359-18363]. Cloning into the NcoI to XhoI sites in pTWIN-MBP1 can be used if a smaller linker is desired.
This results in 3 amino acids attached to the protein's N-terminus and 3 amino acids to its C-terminus.
Two more pTYB C-terminal fusion vectors (pTYB3 NEB#N6703S and pTYB4 NEB#
N6704S) are available for cloning a target gene in which the C-terminus of a target protein is fused in-frame to the N-terminus
of the Sce VMA intein-CBD tag. pTYB3 and pTYB4 contain an NcoI site overlapping the initiating methionine codon in place of the NdeI
site in pTYB1 and pTYB2, respectively. Digestion of the insert with BspHI, BspLU11I, and AflIII can also generate NcoI- compatible
overhangs.
TXB3 ( NEB #N6708) is a IMPACT C-terminal fusion vector that is identical to pTXB1,
except it utilizes the NcoI site overlapping the initiating methionine codon in place of NdeI.
top |
| |
| 1.5.5 What are the components of the IMPACT Kit? |
| |
All components of the IMPACT System are sold separately.
Components of the IMPACT Kit are:
- pTXB1 (#N6707)
- pTYB11 (#N6901)
- pMXB10 (#N6903) - Control plasmid
- E. coli Strain ER2566 – not competent
- Chitin Beads (#S6651)
- 1,4-Dithiothreitol (DTT), 1M
- Anti-Chitin Binding Domain Serum (anti-CBD) (#S6654)
- 3X SDS-PAGE Sample Buffer
- Blue Loading Buffer
- Instruction Manual
A competent version of ER2566, T7 Express Competent E. coli ( NEB #C2566H),
can be purchased separately.
A Special Offer is provided for the IMPACT Kit with T7 Express Cells (#E0543S).
top |
| |
| 1.6 Which inteins are used in the IMPACT vectors? |
| |
The pTXB vectors use an 198 amino acid residue intein from the gyrA gene of Mycobacterium xenopi. The intein
has been engineered for thiol-inducible cleavage at its N-terminus. [Evans, T.C., et al. (1998) Semisynthesis of cytotoxic proteins
using a modified protein splicing element. Protein Sci.7, 2256-2264; Telenti, A., et al. (1997) The Mycobacterium xenopi GyrA protein
splicing element: Characterization of a minimal intein. J. Bacteriol.179, 6378-6382; Southworth, M.W., et al. (1999) Purification of
proteins fused to either the amino or carboxy terminus of the Mycobacterium xenopi Gyrase A intein. BioTechniques27, 110-120.]
The pTYB vectors utilize the intein (454 amino acid residues) from the VMA1 gene of Saccharomyces cerevisiae (Sce VMA intein). The
intein used in the C-terminal fusion vectors (pTYB1-4) is a splicing deficient mutant (carrying Asn454Ala substitution) that only undergoes
N-terminal junction cleavage in the presence of a thiol compound or hydroxylamine. The C-terminal cleavage and splicing activities
have been abolished [Chong et al.,(1996) J. Biol. Chem.271,22159-22168; Chong et al.,(1997) Gene 192,271-281]. In the N-terminal fusion
vectors (pTYB11 and pTYB12) the N-terminus of a target protein is fused to the C-terminus (Asn454) of the intein. The CBD (56 amino
acids) is inserted in a loop region of the intein without affecting its cleavage activity. A sequence consisting of the first 10 residues
of the maltose-binding protein is used as the N-extein sequence to provide a favorable translational start for the fusion protein.
The intein contains a single substitution, which changes its penultimate histidine residue (His453) to a glutamine. These substitutions
allow for the inducible cleavage at both termini of the intein - the thiol-induced cleavage at the N-terminus of the intein/CBD tag
(510 amino acids) triggers the cleavage at the C-terminus tag. [Chong et al.,(1998)J. Biol. Chem.273,10567-10577; Chong et al.,(1998)
Nucl Acids Res.26,5109-5115]
The pTWIN vectors utilize inteins from the Ssp dnaB gene (Ssp DnaB intein, 154 aa), the Mxe gyrA gene (Mxe GyrA intein, 198 aa),
and the Mth rir1 gene (Mth RIR1 intein, 134 aa).
Intein 1 in the pTWIN1, pTWIN2 and pTWIN-MBP1 vectors is a mini-intein of 154 amino acids derived from the Synechocystis sp dnaB gene
[Wu, H., et al. (1998) Biochem Biophys Acta1387, 422-432] engineered to undergo pH (from pH 8.5 to 6) and temperature (from 4 °C
to 20 - 25 °C) dependent
cleavage at its C-terminus. Cleavage of this intein can liberate an N-terminal amino acid residue other than Met on a target protein.
A protein with an N-terminal cysteine residue can be used in IPL reactions. [See Part 6: Applications: Protein ligation and labeling].
In the pTWIN vectors intein2 is either a mini-intein from the Mycobacterium xenopi gyrA gene (pTWIN1) [Telenti, A. et. al. (1997)J.
Bacteriol.179. 6378-6382] or from the Methanobacterium thermoautotrophicum rir1 gene (pTWIN2) [Smith, D. R., et al. (1997) J. Bacteriol.179(22),
7135-7155]. These inteins have been modified to undergo thiol-induced cleavage at their N-terminus. The use of thiol reagents, such
as 2-mercaptoethanesulfonic acid (MESNA), releases a reactive thioester at the C-terminus of the target protein for use in IPL. Following
cleavage the target protein is eluted from the chitin resin while the intein-CBD tag remains bound to the chitin resin.
top |
| |
| 1.7 What causes the cleavage? |
| |
In the C-terminal fusion vectors (pTYB1,2,3,4 and pTXB1,2, ) the engineered intein can undergo a N-S acyl shift to
move the upstream polypeptide (the target protein) to the side chain of the intein N-terminal cysteine to create a thioester linkage
between the cysteine and the preceding residue (the C-terminal residue of a target protein). The thioester bond is susceptible to cleavage
by thiol compounds such as DTT. Thus the equilibrium of the N-S acyl shift can be drastically shifted in the presence of DTT, resulting
in release of the target protein. [Chong et al.,(1998) Gene 192, 271-281; Evans et al., (1998)Protein Sci.7, 2256-2264]
In the N-terminal fusion vectors (pTYB11 and pTYB12) the engineered Sce VMA intein contains a substitution, which changes its penultimate
histidine residue (His453) to a glutamine. This substitution attenuates the succinimide formation by the adjacent C-terminal residue
(Asn454), which, in conjunction with a substitution at the first C-extein residue, allows inducible cleavage at both termini of the
intein. The thiol-induced cleavage at the N-terminus of the intein/CBD tag triggers the cleavage at the C-terminus. [Chong et al.,(1998)
J. Biol. Chem.273,10567-10577; Chong et al.,(1998) Nucl. Acids Res.26,5109-5115]
The pTWIN vectors allow the fusion of Intein2 (either the Mxe GyrA or Mth RIR1 intein) to the C-terminus of a target protein. The
C-terminal residue (an Asn) of the intein has been mutated to an alanine. This blocks the splicing reaction but still allows an N-S
acyl rearrangement to occur at the intein N-terminus (Cys1) resulting in the formation of a thioester linkage between the target protein
and the intein. Cleavage of the thioester bond can be induced by thiol reagents, such as 1,4-dithiothreitol (DTT) or 2-mercaptoethanesulfonic
acid (MESNA). Use of 2-mercaptoethanesulfonic acid results in the formation of a reactive thioester at the C-terminus of the target
protein. This thioester can be used in subsequent IPL reactions.[See Part 6: Applications: Protein ligation and labeling]
For cleavage without the use of a thiol regent, the N-terminus of a target protein can be fused to the C-terminus (an Asn) of Intein1
of the pTWIN vectors (the Ssp DnaB intein). A CBD, present at the N-terminus of the Ssp DnaB intein, facilitates purification using
a chitin resin. The N-terminal cysteine (Cys1) of the intein has been changed to an alanine to block the splicing reaction. The Ssp
DnaB intein with this mutation undergoes a temperature and pH dependent cleavage of the peptide bond between the C-terminus of the
intein and the downstream amino acid. This occurs by the cyclization of the C-terminal Asn side chain to form a succinimide ring with
the concomitant breakage of the peptide bond.[See Part 6: Applications: Protein ligation and labeling]
top |
| |
| 1.7.5 If my target protein is sensitive to DTT , which vector(s) should I use? |
| |
You may use the pTWIN1 or pTWIN2 vector. Fusion of an intein tag (Intein 1) to the N-terminus of a target protein allows
one-column protein purification with a pH (from pH 8.5 to 6) and temperature (from 4 °C to 20 - 25 °C) shift. No thiol reagents
are required for cleavage.
he N-terminus of a target protein can be fused to the C-terminus (an Asn) of Intein1 of the pTWIN vectors (the Ssp DnaB intein). A
CBD, present at the N-terminus of the Ssp DnaB intein, facilitates purification using a chitin resin. The N-terminal cysteine (Cys1)
of the intein has been changed to an alanine to block the splicing reaction. The Ssp DnaB intein with this mutation undergoes a temperature
and pH dependent cleavage of the peptide bond between the C-terminus of the intein and the downstream amino acid. This occurs by the
cyclization of the C-terminal Asn side chain to form a succinimide ring with the concomitant breakage of the peptide bond. Intein 1
fusions are used to generate proteins with an N-terminal cysteine. [See Part
6: Applications/Ligation(IPL) and TWIN]
top |
| |
| 1.8 What is the success rate of procaryotic protein purification? |
| |
80% of the prokaryotic proteins tested with the IMPACT System were expressed and purified with yields ranging from 0.5-30
mg/liter culture. 50% of these proteins were purified with their native sequences (no vector derived residues).
top |
| |
| 1.9 What size range of proteins have been purified? |
| |
The size range of proteins we have purified from E.coli host cells is up to 124 kDa.
top |
| |
| 1.10 IMPACT References: |
| |
pTYB1-4, pCYB1-4
Chong, S., Mersha, F.B., Comb, D.G., Scott, M. E., Landry, D., Vence, L.M., Perler, F.B., Benner, J., Kucera, R.B., Hirvonen, C.A.,
Pelletier, J.J., Paulus, H., and Xu, M.-Q. (1997). Single-column purification of free recombinant proteins using a self-cleavable affinity
tag derived from a protein splicing element. Gene 192, 271-281. PubMed ID: 9224900
pTYB11,12
Chong, S., Montello, G.E., Zhang, A., Cantor, E.J., Liao, W., Xu, M-Q., and Benner, J. (1998) Utilizing the C-terminal cleavage activity
of a protein splicing element to purify recombinant proteins in a single chromatographic step. Nucleic Acids Res. 26,
5109-5115. PubMed ID: 9801307
Chong, S., Williams, K. S., Wotkowicz, C., and Xu, M. Q. (1998). Modulation of protein splicing of the Saccharomyces cerevisiae vacuolar
membrane ATPase intein. J. Biol. Chem. 273:10567-77. PubMed ID: 9553117
pTXB1,3
Evans, T.C. Jr., Benner, J., and Xu, M.-Q. (1998) Semisynthesis of cytotoxic proteins using a modified protein splicing element. Protein
Sci. 7, 2256-2264. PubMed ID: 9827992
Southworth, M.W., Amaya, K., Evans, T.C., Xu, M.-Q., and Perler, F.B. (1999) Purification of proteins fused to either the amino
or carboxy terminus of the Mycobacterium xenopi Gyrase A intein. BioTechniques 27, 110-120. PubMed ID: 10407673
pTWIN1,2
Evans, T.C. Jr., Benner, J., and Xu, M.-Q.(1999) The cyclization and polymerization of bacterially-expressed proteins using modified
self-splicing inteins. J. Biol. Chem. 274, 18359-18363. PubMed ID: 10373440
Evans, T.C. Jr., Benner, J., and Xu, M.-Q. (1999) The in vitro ligation of bacterially expressed protein using an intein from Methanobacterium
thermoautotrophicum. J. Biol. Chem. 274, 3923-3926. PubMed ID: 9933578
Mathys, S., Evans, T.C. Jr., Chute, I.C., Wu, H., Chong, S., Benner, J., Liu, X.-Q., Xu, M.-Q. (1999) Characterization of a self-splicing
mini-intein and its conversion into autocatalytic N- and C-terminal cleavage elements: facile production of protein building blocks
for protein ligation. Gene, 231:1-13. PubMed ID: 10231563
Reviews
Xu, M.Q., Paulus, H. and Chong, S. (2000) Fusions to self-splicing inteins for protein purification. Methods Enzymol. 326:376-418.
PubMed ID: 11036654
Evans T. C. & Xu, M.-Q, (1999) Intein-mediated protein ligation: harnessing nature's escape artists. Biopolymers 51, 333-42.
PubMed ID: 10685044
For additional references see InBase, the Intein registry Web site at <http://www.neb.com/neb/inteins.html>
top |
| |
| 1.11 References from IMPACT Users: |
| _____ |
Protein Purification
Wojtaszek, J.; Kolaczkowska, A.; Kowalska, J.; Nowak, K.; Wilusz, T. (2006) LTCI, a novel chymotrypsin inhibitor of the potato I family
from the earthworm Lumbricus terrestris. Purification, cDNA cloning, and expression. Comp. Biochem.
Physiol B. Biochem. Mol. Biol. 143 (4): 465-472. (pTYB11) PubMed ID: 16469515
Goodin, J. L.; Raab, R. W.; McKown, R. L.; Coffman, G. L.; Powell, B. S.; Enama, J. T.; Ligon, J. A.; Andrews, G. P. (2005) Yersinia
pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum. Protein
Expr. Purif. 40 (1): 152-63. (pTYB11) PubMed ID: 15721783
Ingham, A.B., Sproat, K.W., Tizard, M.L., Moore, R.J. (2005) A versatile system for the expression of nonmodified bacteriocins in
Escherichia coli. J. Appl. Microbiol. 98(3):676-83. PubMedID: 15715871 (pTYB1)
Morassutti, C.; De Amicis, F.; Bandiera, A.; Marchetti, S. (2005) Expression of SMAP-29 cathelicidin-like peptide in bacterial cells
by intein-mediated system. Protein Expr. Purif. 39 (2): 160-8. (pCYB1, pTYB11) PubMed ID: 15642466
Rebets, Y., Ostash, B., Luzhetskyy, A., Kushnir, S., Fukuhara, M., Bechthold, A., Nashimoto, M., Nakamura, T., and Fedorenko, V. (2005)
DNA-binding activity of LndI protein and temporal expression of the gene that upregulates landomycin E production in Streptomyces globisporus
1912. Microbiology. 281-90. (pTYB2) PubMedID: 15632445
Grzybowska, B., Szweda, P. and Synowiecki, J. (2004) Cloning of the thermostable alpha-amylase gene from Pyrococcus woesei in Escherichia
coli: isolation and some properties of the enzyme. Mol. Biotechnol. 26(2):101-10. (pTYB2) PubMedID: 14764935
Guo, C., Li, Z., Shi, Y., Xu, M., Wise, J.G., Trommer, W.E., and Yuan, J. (2004) Intein-mediated fusion expression, high efficient
refolding, and one-step purification of gelonin toxin. Protein Expr Purif. 37:361-7. PMID: 15358358
Ma, J. and Cooney, C.L. (2004) Application of Vortex Flow Adsorption Technology to Intein-Mediated Recovery of Recombinant Human
alpha1 antityrpsin. Biotechnol. Prog. 20, 269-276. (pTYB12) PubMedID: 14763852
Vann, W.F., Daines, D.A., Murkin, A.S., Tanner, M.E., Chaffin, D.O., Rubens, C.E., Vionnet, J. and Silver, R.P. (2004) The NeuC protein
of Escherichia coli K1 is a UDP N-acetylglucosamine 2-epimerase. J. Bacteriol. 186:706-12 (pCYB4) PubMedID: 14729696
Yu, R.J., Hong, A., Dai, Y. and Gao Y. (2004) Intein-mediated rapid purification of recombinant human pituitary adenylate cyclase
activating polypeptide. Acta Biochim Biophys Sin (Shanghai). 36(11):759-66 (pKYB1) PubMedID: 15514850
Bonsager, B.C., Praetorius-Ibba, M., Nielsen, P.K., and Svensson, B. (2003) Purification and characterization of the beta-trefoil
fold protein barley alpha-amylase/subtilisin inhibitor overexpressed in Escherichia coli. Protein Expr. Purif. (2):185-93.
(pTYB1) PubMedID: 12880767
Chorostowska-Wynimko, J.; Swiercz, R.; Skrzypczak-Jankun, E.; Wojtowicz, A.; Selman, S. H.; Jankun, J. (2003) A novel form of the
plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis. Mol.
Cancer Ther. 2(1): 19-28. (pTYB12) PubMed ID: 12533669
Pinto, A.P., Campana, P.T., Beltramini, L.M., Silber, A.M. and Araujo, A.P. (2003) Structural characterization of a recombinant flagellar
calcium-binding protein from Trypanosoma cruzi. Biochim. Biophys. Acta. 1652(2):107-14. (pTYB2) PubMedID: 14644046
Salazar, J.C., Ahel, I., Orellana, O., Tumbula-Hansen, D., Krieger, R., Daniels, L., and Soll, D. (2003) Coevolution of an aminoacyl-tRNA
synthetase with its tRNA substrates. Proc. Natl. Acad. Sci. U S A. 100(24):13863-8. (pTYB1)
PubMedID: 14615592
Schaffer, L., Brissette, R.E., Spetzler, J.C., Pillutla, R.C., Ostergaard, S., Lennick ,M., Brandt, J., Fletcher, P.W., Danielsen,
G.M., Hsiao, K.C., Andersen, A.S., Dedova, O., Ribel, U., Hoeg-Jensen, T., Hansen, P.H., Blume, A.J., Markussen, J., and Goldstein,
N.I. (2003) Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks. Proc.
Natl. Acad. Sci. USA. 100(8):4435-9. PubMedID : 12684539
Wuebbens, M. M.; Rajagopalan, K. V. (2003) Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the
final step of molybdopterin biosynthesis. J. Biol. Chem. 278 (16): 14523-32. (pTYB3) PubMed
ID: 12571226
Humphries, H. E.; Christodoulides, M.; Heckels, J. E. (2002) Expression of the class 1 outer-membrane protein of Neisseria meningitidis
in Escherichia coli and purification using a self-cleavable affinity tag. Protein Expr. Purif. 26
(2): 243-8. (pTWIN 1) PubMed ID: 12406678
Min, B., Pelaschier, J.T., Graham, D.E., Tumbula-Hansen, D., and Soll, D. (2002) Transfer RNA-dependent amino acid biosynthesis:
an essential route to asparagine formation. Proc. Natl. Acad. Sci. U S A. 99(5): 2678-83. (pCYB2)
PubMedID : 11880622
Moolenaar GF, van Rossum-Fikkert S, van Kesteren M, Goosen N. (2002) Cho, a second endonuclease involved in Escherichia coli nucleotide
excision repair. Proc. Natl. Acad. Sci. USA. 99(3):1467-72. (pTYB1) PubMedID : 11818552
Morassutti, C, DeAmicis, F, Skerlavaj, B, Zanetti, M, and Marchetti, S. (2002) Production of a recombinant antimicrobial peptide in
transgenic plants using a modified VMA intein expression system. FEBS Letters. 519: 141-146. PubMedID: 12023033
Nakano, S., Zheng, G., Nakano, M.M. and Zuber, P. (2002) Multiple pathways of Spx (YjbD) proteolysis in Bacillus subtilis. J. Bacteriol
184(13):3664-70. (pTYB1, pTYB2) PubMedID : 12057962
Singleton, S. F.; Simonette, R. A.; Sharma, N. C.; Roca, A. I. (2002) Intein-mediated affinity-fusion purification of the Escherichia
coli RecA protein. Protein Expr. Purif. 26 (3): 476-88. (pTXB3) PubMed ID: 12460773
Wojciak, J.M., Sarkar, D., Landy, A., and Clubb, R.T. (2002) Arm-site binding by lambda -integrase: solution structure and functional
characterization of its amino-terminal domain. Proc. Natl. Acad. Sci. U S A. 99(6):3434-9. (pTYB11)
PubMedID : 11904406
Wojciechowski CL, Cardia JP, and Kantrowitz ER. (2002) Alkaline phosphatase from the hyperthermophilic bacterium T. maritima requires
cobalt for activity. Protein Sci.4:903-911. (pTYB12) PubMedID: 11910033
Zhong, Q., Lazar, C.S., Tronchere, H., Sato, T., Meerloo, T., Yeo, M., Songyang, Z., Emr, S.D. and Gill, G.N. (2002) Endosomal localization
and function of sorting nexin 1. Proc. Natl. Acad. Sci. U S A. 99(10): 6767-72. PubMedID: 11997453
Cottingham IR, Millar A, Emslie E, Colman A, Schnieke AE and McKee C.(2001) A method for the amidation of recombinant peptides expressed
as intein fusion proteins in Escherichia coli. Nat. Biotechnol. 10:974-977.(pTYB1, pCYB1) PubMedID: 11581666
Dorsch, S., Kaufmann, B., Schaible, U., Prohaska, E., Wolf, H., and Modrow, S. (2001) The VP1-unique region of parvovirus B19: amino
acid variability and antigenic stability. J. Gen. Virol. 82 (pt 1) 191-9. PubMed ID:11125172
Hanzawa, H., Inomata, K., Kinoshita, H., Kakiuchi, T., Jayasundera, K.P., Sawamoto, D., Ohta, A., Uchida, K., Wada, K. and Furuya,
M. (2001) In vitro assembly of phytochrome B apoprotein with synthetic analogs of the phytochrome chromophore. Proc.
Natl. Acad. Sci. USA. 98(6):3612-7. (pTYB2) PubMedID : 11248126
Hong, S.H., Toyama, M., Maret, W., and Murooka, Y. (2001) High Yield Expression and Single Step Purification of Human Thionein/Metallothionein Protein
Expr Purif. 21, 243-250. (pTYB11) PubMed ID:11162412
Mukhopadhyay, J.; Kapanidis, A. N.; Mekler, V.; Kortkhonjia, E.; Ebright, Y. W.; Ebright, R. H. (2001) Translocation of sigma(70)
with RNA polymerase during transcription: fluorescence resonance energy transfer assay for movement relative to DNA. Cell.
106 (4): 453-63. (pCYB2) PubMed ID: 11525731
Paul R, Bosch FU, and Schafer KP. (2001) Overexpression and purification of Helicobacter pylori flavodoxin and induction of a specific
antiserum in rabbits. Protein Expr. Purif. 3:399-405. (pTYB1) PubMedID: 11483001
Saiki, K.; Konishi, K.; Gomi, T.; Nishihara, T.; Yoshikawa, M. (2001) Reconstitution and purification of cytolethal distending toxin
of Actinobacillus actinomycetemcomitans. Microbiol. Immunol. 45 (6): 497-506. (pTYB4) PubMed
ID: 11497226
Szweda P, Pladzyk R, Kotlowski R, and Kur J. (2001). Cloning, expression, and purification of the Staphylococcus simulans lysostaphin
using the intein-chitin-binding domain (CBD) system. Protein Expr Purif. 3:467-471. (pTYB12) PubMedID: 11483010
Thomson CA, and Ananthanarayanan VS. (2001) A method for expression and purification of soluble, active Hsp47, a collagen-specific
molecular chaperone. (pTYB4) Protein Expr. Purif. (1):8-13. PubMed ID: 11570840
Park, C.M., Kim, J.I., Yang, S.S., Kang, J.G., Kang, J.H., Shim, J.Y., Chung,Y.H., Park, Y.M., and Song, P.S. (2000) A Second Photochromic
Bacteriophytochrome from Synechocystis sp. PCC 6803: Spectral Analysis and Down-Regulation by Light. Biochemistry. 39, 10840-10847.
(pTYB2) PubMed ID:10978170
Raibekas, A.A., Fukui, K. and Massey, V. (2000) Design and properties of human D-amino acid oxidase with covalently attached flavin. Proc.
Natl. Acad. Sci. USA. 97(7):3089-93. (pTYB2) PubMed ID: 10716694
Wu, C., Seitz, P.K, and Falzon, M. (2000). Single-column purification and bio-characterization of recombinant human parathyroid
hormone-related protein Mol. Cell Endocrinol 170, 163-174. (pTYB1). PubMed ID:11162900
Yuan, J.M., Li, Z.Y., Wang, Y.M., and Xu, M.-Q. (2000). One step purification of recombinant human Neurotrophic factor-3 with
the splicing function of intein. Chin. J. Biochem. Mol. Biol 16, 335-339. (pTXB1)
Gilbert, M. and Stayton, P.S. (1999) Expression and characterization of human salivary statherin from Escherichia coli using
two different fusion constructs. Protein Expr. Purif. 16, 243-50. (pCYB1). PubMed ID:10419821
Kutchma, A.J., Hoang, T.T., Schweizer, H.P. (1999) Characterization of a Pseudomonas aeruginosa Fatty Acid Biosynthetic Gene Cluster:
Purification of Acyl Carrier Protein (ACP) and Malonyl-Coenzyme A:ACP Transacylase (FabD) J. Bacteriol. 181, 5498-5504. (pCYB1)
PubMed ID:10464226
Morris SK, Harkins TT, Tennyson RB, Lindsley JE. (1999) Kinetic and thermodynamic analysis of mutant type II DNA topoisomerases that
cannot covalently cleave DNA. J. Biol. Chem. 274(6):3446-52. (pCYB2) PMID: 9920889
Pradhan, S., Bacolla, A., Wells, R.D, and Roberts R.J. (1999) Recombinant human DNA (cytosine-5) methyltransferase. I. Expression,
purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 274, 33002-10. PubMed ID:10551868
Qi, Z., Hamza, I., O'Brian, M.R. (1999) Heme is an effector molecule for iron-dependent degradation of the bacterial iron response
regulator (Irr) protein. Proc. Natl. Acad. Sci. USA 96(23):13056-61. (pCYB1) PMID: 10557272
Welker, E., and Scheraga, H.A. (1999) Use of Benzyl Mercaptan for Direct Preparation of Long Polypeptide Benzylthio Esters as Substrates
of Subtiligase. Biochem. Biophys. Res. Comm. 254, 147-151. (pMYB129-derivative of pCYB1) PubMed ID: 9920748
Schleper, C., Swanson, R.V., Mathur, E.J., and DeLong, E.E. (1997). Characterization of a DNA Polymerase from the Uncultivated Psychrophilic
Archaeon Cenarchaeum symbiosum. J. Bacteriology 179, 7803-7811. (pCYB2) PubMed ID: 9401041
Protein labeling, ligation and cyclization
Durek, T., Alexandrov, K., Goody, R.S., Hildebrand, A., Heinemann, I., and Waldmann,H. (2004) Synthesis of fluorescently labeled
mono- and diprenylated Rab7 GTPase. | | |